Clinical trials recruiting in Gauteng, South Africa
3
Recruiting trials
8
Conditions
Phase breakdown
Phase 3 3
Conditions recruiting in Gauteng, South Africa
| Condition | Trials |
|---|---|
| Hypertension | 2 |
| Cardiovascular Diseases | 1 |
| Diabetes Mellitus, Type 2 | 1 |
| HIV | 1 |
| HIV Infections | 1 |
| High Cardiovascular Risk | 1 |
| High Risk Cardiovascular Disease | 1 |
| Type 2 diabetes | 1 |
Recruiting trials in Gauteng, South Africa
- A Continued Access Study for Participants Transitioning From ViiV Healthcare-sponsored or ViiV Healthcare-collaborative Parent Studies for HIV Treatment
- EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
- Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease
Common questions
How many clinical trials are recruiting in Gauteng, South Africa?
3 recruiting trials have at least one study site in Gauteng, South Africa.
Is this list complete?
No. For the full record, search ClinicalTrials.gov.